{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "98694",
      "recalling_firm": "Wells Pharma of Houston LLC",
      "address_1": "9265 Kirby Dr",
      "address_2": "",
      "postal_code": "77054-2520",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide.",
      "recall_number": "D-0506-2026",
      "product_description": "fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well pharma of Houston, NDC  73702-203-65.",
      "product_quantity": "150 syringes",
      "reason_for_recall": "cGMP deviations.",
      "recall_initiation_date": "20260401",
      "center_classification_date": "20260428",
      "report_date": "20260506",
      "code_info": "Lot 022326203650432; Exp Date 06/25/2026",
      "more_code_info": ""
    }
  ]
}